SCHEMBL2720403

SCHEMBL2720403

CN1CCC(OC(c2ccc3occc3c2)c2nc3ccccc3s2)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 2/20 0.43
SLC6A3 Q01959 2/20 0.43
CYP2D6 P10635 2/20 0.43
HRH3 Q9Y5N1 2/20 0.43
CHRM2 P08172 1/20 0.43
HTR1A P08908 1/20 0.43
ADRA2A P08913 1/20 0.43
CHRM1 P11229 1/20 0.43
DRD1 P21728 1/20 0.43
ADRA1A P35348 1/20 0.43
OPRM1 P35372 1/20 0.43
DRD3 P35462 1/20 0.43
KCNH2 Q12809 1/20 0.43
MAPK1 P28482 2/20 0.42
GAA P10253 1/20 0.36
TSHR P16473 1/20 0.36
SLC6A4 P31645 2/20 0.35
OGA O60502 3/20 0.34
APEX1 P27695 1/20 0.33
HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2722795 0.87 CHRM2 (0.47) SLC6A2SLC6A3CYP2D6HRH3CHRM2
SCHEMBL900566 0.83 CHRM2 (0.63) SLC6A2SLC6A3CYP2D6HRH3CHRM2
SCHEMBL900092 0.83 CHRM2 (0.63) SLC6A2SLC6A3CYP2D6HRH3CHRM2
SCHEMBL900508 0.83 CHRM2 (0.51) SLC6A2SLC6A3CYP2D6HRH3CHRM2
SCHEMBL900353 0.83 OGA (0.46) SLC6A2SLC6A3CYP2D6HRH3CHRM2
SCHEMBL2722779 0.83 OGA (0.52) SLC6A2SLC6A3CYP2D6HRH3CHRM2
SCHEMBL2722079 0.83 CHRM2 (0.52) SLC6A2SLC6A3CYP2D6HRH3CHRM2
SCHEMBL2720681 0.82 CHRM2 (0.49) SLC6A2SLC6A3CYP2D6HRH3CHRM2
SCHEMBL2719906 0.82 DRD3 (0.51) SLC6A2SLC6A3CYP2D6HRH3CHRM2
SCHEMBL2720633 0.82 CHRM1 (0.51) SLC6A2SLC6A3CYP2D6HRH3CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2621916-B1 BENZAZOLE DERIVATIVES AS HISTAMINE H4 RECEPTOR LIGANDS BIOPROJET SOC CIV (FR) 2016-02-10 EP claimed
EP-3378476-A1 H4 RECEPTOR INHIBITORS FOR TREATING TINNITUS Sensorion (FR) 2018-09-26 EP disclosed
US-9688989-B2 H4 receptor inhibitors for treating tinnitus SENSORION (FR) 2017-06-27 US disclosed
EP-2621916-B1 BENZAZOLE DERIVATIVES AS HISTAMINE H4 RECEPTOR LIGANDS BIOPROJET SOC CIV (FR) 2016-02-10 EP disclosed
US-20150176010-A1 H4 RECEPTOR INHIBITORS FOR TREATING TINNITUS SENSORION (FR) 2015-06-25 US disclosed
EP-2858647-A1 H4 RECEPTOR INHIBITORS FOR TREATING TINNITUS Sensorion (FR) 2015-04-15 EP disclosed
WO-2013182711-A1 H4 RECEPTOR INHIBITORS FOR TREATING TINNITUS SENSORION (FR) 2013-12-12 WO disclosed
EP-2447263-A1 Benzazole derivatives as histamine H4 receptor ligands BIOPROJET (FR) 2012-05-02 EP disclosed